Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7438 p154
10 February 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Fraud savings reach £800m

Savings for the NHS in England since it started to tackle losses due to fraud seven years ago have reached £811m. This is a 12:1 return on investment in counter-fraud work.

There have been 360 prosecutions (with a 96 per cent success rate) and 434 civil and disciplinary actions against members of the public and NHS staff who have committed fraud.

The latest figures were announced last month, together with the departure of the NHS’s director of counter-fraud services Jim Gee. Mr Gee has moved to accountancy and consulting firm KPMG.

Wales Counter fraud work in Wales has recovered £1.766m since August 2001.

Back to Top


©The Pharmaceutical Journal